IMS Health Cuts Pharma Growth Forecast

The recession is taking a toll on growth in the pharmaceutical industry, according to a closely watched forecast by IMS Health

Big Pharma isn't so immune to the recession after all. In an indication the deterioration of the global economy is hitting drugmakers, a research group said on Apr. 22 that it's cutting a closely watched forecast for industry growth.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.